Results 101 to 110 of about 28,261 (176)

Summary of anti-EBOV GP IgG ELISA qualification results.

, 2019
Summary of anti-EBOV GP IgG ELISA qualification results.
Karen A. Sankovich (6612491), Nick D. Skomrock (6612500), Michael S. Anderson (6612497), Christopher S. Badorrek (2522851), Chris M. Cirimotich (6612503), Thomas L. Rudge Jr. (6612488), Nancy A. Niemuth (6612494), Carol L. Sabourin (6612506)   +7 more
core   +1 more source

Epidemiological and genetic parameters for EBOV and SARS-CoV.

, 2019
Epidemiological and genetic parameters for EBOV and SARS-CoV.
Thibaut Jombart (250577), Neil Ferguson (230990), Finlay Campbell (4840515), Anne Cori (260622)   +3 more
core   +1 more source

Development of a Pentacistronic Ebola Virus Minigenome System

Viruses
Ebola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-
Brady N. Zell, Vaille A. Swenson, Shao-Chia Lu, Lin Wang, Michael A. Barry, Hideki Ebihara, Satoko Yamaoka   +6 more
doaj   +1 more source

Association between potential risk factors and anti-EBOV IgG seropositivity.

, 2015
Association between potential risk factors and anti-EBOV IgG seropositivity.
Ernest A. Gould (24586), Hervé Richet (13457), Yannik Boehmann (749966), Pierre Gallian (749967), Stephan Günther (218223), Xavier de Lamballerie (95840), Petra Emmerich (331026), Amelia Dzia-Lepfoundzou (749965), Yannick Dimi (679317), Nanikaly Moyen (402988), Laurence Thirion (230519)   +10 more
core   +1 more source

Kaplan Meier survival curves of guinea pigs after EBOV infection, according to treatment with anti-EBOV IgGs.

, 2016
A: Survival of guinea pigs having received the anti-EBOV IgGs (n = 10) compared to guinea pigs receiving the non-immune DKO IgGs (n = 5, *p = 0.0424, using a Log Rank test).
Hélène Perreault (2825738), Andrea Perota (2825711), Hoa Le Mai (2825729), Hervé Raoul (288207), Ludmilla Le Berre (2825741), Gwénaëlle Evanno (2825708), Cesare Galli (2825717), Giovanna Lazzari (2825726), Sophie Conchon (2825744), Jean-Marie Bach (627439), Olivier Reynard (354756), Frédéric Jacquot (2825714), Apolline Salama (627431), Bernard Martinet (2825705), Viktor Volchkov (354761), Jean-Paul Judor (2825735), Odile Duvaux (2825732), Elsa Lheriteau (2825723), Irina Lagutina (2825747), Jean-Paul Soulillou (216558), Roberto Duchi (2825720)   +20 more
core   +1 more source

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea

Nature Communications
Human Ebola virus (EBOV) outbreaks caused by persistent EBOV infection raises questions on the role of zoonotic spillover in filovirus epidemiology. To characterise filovirus zoonotic exposure, we collected cross-sectional serum samples from bushmeat ...
Joseph Akoi Boré, Joseph W. S. Timothy, Tom Tipton, Ifono Kekoura, Yper Hall, Grace Hood, Stephanie Longet, Kimberly Fornace, Millimono S. Lucien, Sarah Katarina Fehling, Beatrice K. Koivogui, Si’Ana A. Coggins, Eric D. Laing, Christopher C. Broder, N’ Faly Magassouba, Thomas Strecker, Jeremy Rossman, Kader Konde, Miles W. Carroll   +18 more
doaj   +1 more source

IFNγ-treated macrophages are resistant to EBOV infection.

, 2015
(A) IFNγ/TNFα treatment inhibits EBOV infection of BALB/c peritoneal macrophages. Cultures maintained in media containing GM-CSF or M-CSF were treated with murine IFNγ/TNFα 24 hours prior to EBOV-GFP infection (MOI = 0.05 in Vero E6 cells). Shown are the
Wendy Maury (33779), Patrick Sinn (825671), Robert A. Davey (95393), Kai Rogers (825668), Bethany A. Rhein (825667), Brajesh K. Singh (197177), Thomas Bair (137547), Manu Anantpadma (825669), Martha M. Monick (309723), Linda S. Powers (309718), Catherine Miller-Hunt (825670), Yasuteru Sakurai (589426)   +11 more
core   +1 more source

Detection of EBOV in challenged NHPs.

, 2014
Plasma samples from each NHP were assayed for the presence of EBOV by real-time PCR (A) and by plaque assay (B). Samples were run singly due to limited plasma availability. (C) Plasma samples were also assessed using the filovirus SCP panel.
Jeffrey W. Koehler (259360), Anna N. Honko (364644), P. Alexander Rolfe (139586), Joseph N. Fair (131472), Timothy D. Minogue (628045), Adeyemi Adesokan (628044), Adrienne T. Hall (628040), Prime Mulembekani (628042), Randal J. Schoepp (628043), Gustavo F. Palacios (628041), Jean-Jacques Muyembe (116139)   +10 more
core   +1 more source

A protein-proximity screen reveals Ebola virus co-opts the mRNA decapping complex through the scaffold protein EDC4

Nature Communications
The interaction of host and Ebola virus (EBOV) proteins is required for establishing infection. In this study, we use proximity-dependent biotinylation to identify cellular proteins that bind to EBOV proteins encoded by six of the seven viral genes. Hits
Callie J. Donahue, Aditi S. Kesari, Naveen Thakur, Ling Wang, Sarah Hulsey Stubbs, Caroline G. Williams, Sandhya Bharti Sharma, Cara D. Kirby, Daisy W. Leung, Uma K. Aryal, Christopher F. Basler, Douglas J. LaCount, Robert A. Davey   +12 more
doaj   +1 more source

Identification of FcγRIIa-mediated signaling pathway for EBOV ADE.

, 2017
K562 cells were treated with the indicated concentrations of R788, PP2, LFM-A13, LY294002, or Manumycin A for 1 h at 37°C and inoculated with VSV-EBOV GP or EBOV preincubated with CTR IgG, or ZGP12/1.1.
Andrea Marzi (146489), Ayato Takada (18295), Junki Maruyama (446863), Hiroko Miyamoto (150575), Rashid Manzoor (446864), Wakako Furuyama (152689), Asuka Nanbo (241624), Reiko Yoshida (150578), Manabu Igarashi (150572), Aaron B. Carmody (215729), Makoto Kuroda (249974), Heinz Feldmann (18301)   +11 more
core   +1 more source